IGFBP4 and atrial fibrillation: In a recent study on maternal serum, Saade et al. have demonstrated that an elevated serum IGFBP-4 level at 17–28 weeks may be a useful predictor for identifying asymptomatic pregnant women at risk of SPTD43, similarly to the results obtained in the current study using AF samples.